FDA Approved: ORLADEYO — Original Application (BioCryst Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ORLADEYO (berotralstat hydrochloride) from BioCryst Pharmaceuticals via an original application for prophylaxis to prevent attacks in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• ORLADEYO (berotralstat hydrochloride)

Snippet

ORIG AP for ORLADEYO (BEROTRALSTAT HYDROCHLORIDE)